Literature DB >> 28409593

Chronic Obstructive Pulmonary Disease: Diagnosis and Management.

Shari Gentry1, Barry Gentry2.   

Abstract

The diagnosis of chronic obstructive pulmonary disease (COPD) should be suspected in patients with risk factors (primarily a history of smoking) who report dyspnea at rest or with exertion, chronic cough with or without sputum production, or a history of wheezing. COPD may be suspected based on findings from the history and physical examination, but must be confirmed by spirometry to detect airflow obstruction. Findings that are most helpful to rule in COPD include a smoking history of more than 40 pack-years, a self-reported history of COPD, maximal laryngeal height, and age older than 45 years. The combination of three clinical variables-peak flow rate less than 350 L per minute, diminished breath sounds, and a smoking history of 30 pack-years or more-is another good clinical predictor, whereas the absence of all three of these signs essentially rules out airflow obstruction. Pharmacotherapy and smoking cessation are the mainstays of treatment, and pulmonary rehabilitation, long-term oxygen therapy, and surgery may be considered in select patients. Current guidelines recommend starting monotherapy with an inhaled bronchodilator, stepping up to combination therapy as needed, and/or adding inhaled corticosteroids as symptom severity and airflow obstruction progress.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28409593

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  5 in total

1.  A snapshot of chronic obstructive pulmonary disease management in general practice in Ireland.

Authors:  Liam O'Halloran; Amy Purcell; Eoin Ryan; Jane O'Doherty; Louise Troddyn; Martin Slepanek; Neil O'Driscoll; Orlaith O'Reilly; Paul Stassen; Sarah Anne Bennett; Raymond O'Connor
Journal:  Ir J Med Sci       Date:  2020-11-20       Impact factor: 1.568

2.  Predifferentiated amniotic fluid mesenchymal stem cells enhance lung alveolar epithelium regeneration and reverse elastase-induced pulmonary emphysema.

Authors:  Ying-Wei Lan; Jing-Chan Yang; Chih-Ching Yen; Tsung-Teng Huang; Ying-Cheng Chen; Hsiao-Ling Chen; Kowit-Yu Chong; Chuan-Mu Chen
Journal:  Stem Cell Res Ther       Date:  2019-06-13       Impact factor: 6.832

3.  Type 2 diabetes and COPD: treatment in the right healthcare setting? An observational study.

Authors:  R P Willink; Rimke C Vos; I Looijmans-van den Akker; Huberta E Hart
Journal:  BMC Fam Pract       Date:  2021-04-20       Impact factor: 2.497

4.  Effect of Enteral and Parenteral Nutrition Support on Pulmonary Function in Elderly Patients with Chronic Obstructive Pulmonary Disease Complicated by Respiratory Failure.

Authors:  Liangge Wang; Wenxiu Rui; Si Chen; Yazhou Li; Minhuan Ren
Journal:  Comput Math Methods Med       Date:  2022-10-05       Impact factor: 2.809

5.  Liuweibuqi capsules improve pulmonary function in stable chronic obstructive pulmonary disease with lung-qi deficiency syndrome by regulating STAT4/STAT6 and MMP-9/TIMP-1.

Authors:  Dan-Dan Shen; Zhong-Hui Yang; Ji Huang; Fei Yang; Zi-Wei Lin; Ying-Fei Ou; Min-Hao Hu
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.